{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:15Z","timestamp":1790808195552,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1118-7","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T07:30:12Z","timestamp":1475479812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator"],"prefix":"10.1186","volume":"18","author":[{"given":"Swati","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren Van Duyn","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"issue":"3","key":"1118_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117(3):557\u201367.","journal-title":"J Clin Invest"},{"issue":"4","key":"1118_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","volume":"5","author":"J Varga","year":"2009","unstructured":"Varga J, Pasche B. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol. 2009;5(4):200\u20136.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1118_CR3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","volume":"17","author":"S Bhattacharyya","year":"2015","unstructured":"Bhattacharyya S, Varga J. Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep. 2015;17(1):474.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"1118_CR4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri3095","volume":"11","author":"KH Mills","year":"2011","unstructured":"Mills KH. TLR-dependent T, cell activation in autoimmunity. Nat Rev Immunol. 2011;11(12):807\u201322.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1118_CR5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol. 2012;8(1):42\u201354.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1118_CR6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/imr.12381","volume":"269","author":"JA Hamerman","year":"2016","unstructured":"Hamerman JA, Pottle J, Ni M, He Y, Zhang ZY, Buckner JH. Negative regulation of TLR signaling in myeloid cells-implications for autoimmune diseases. Immunol Rev. 2016;269(1):212\u201327.","journal-title":"Immunol Rev"},{"issue":"11","key":"1118_CR7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri3313","volume":"12","author":"A Ma","year":"2012","unstructured":"Ma A, Malynn BA. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol. 2012;12(11):774\u201385.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1118_CR8","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/art.34490","volume":"64","author":"E Koumakis","year":"2012","unstructured":"Koumakis E, Giraud M, Dieude P, Cohignac V, Cuomo G, Airo P, Hachulla E, Matucci-Cerinic M, Diot E, Caramaschi P, et al. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. Arthritis Rheum. 2012;64(8):2746\u201352.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1118_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","volume":"94","author":"MD Mayes","year":"2014","unstructured":"Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, Assassi S, Ying J, Tan FK, Arnett FC, et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014;94(1):47\u201361.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1118_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-014-0484-x","volume":"17","author":"BD Korman","year":"2015","unstructured":"Korman BD, Criswell LA. Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance. Curr Rheumatol Rep. 2015;17(3):21.","journal-title":"Curr Rheumatol Rep"},{"issue":"5488","key":"1118_CR11","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"EG Lee","year":"2000","unstructured":"Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289(5488):2350\u20134.","journal-title":"Science"},{"issue":"232","key":"1118_CR12","doi-asserted-by":"crossref","first-page":"232ra250","DOI":"10.1126\/scitranslmed.3008264","volume":"6","author":"S Bhattacharyya","year":"2014","unstructured":"Bhattacharyya S, Tamaki Z, Wang W, Hinchcliff M, Hoover P, Getsios S, White ES, Varga J. Fibronectin EDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci Transl Med. 2014;6(232):232ra250.","journal-title":"Sci Transl Med"},{"issue":"2","key":"1118_CR13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.4131","volume":"229","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S, Fang F, Tourtellotte W, Varga J. Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol. 2013;229(2):286\u201397.","journal-title":"J Pathol"},{"issue":"1","key":"1118_CR14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","volume":"182","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S, Kelley K, Melichian DS, Tamaki Z, Fang F, Su Y, Feng G, Pope RM, Budinger GR, Mutlu GM, et al. Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol. 2013;182(1):192\u2013205.","journal-title":"Am J Pathol"},{"issue":"38","key":"1118_CR15","doi-asserted-by":"crossref","first-page":"25569","DOI":"10.1074\/jbc.M109.019786","volume":"284","author":"EJ Folco","year":"2009","unstructured":"Folco EJ, Rocha VZ, Lopez-Ilasaca M, Libby P. Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem. 2009;284(38):25569\u201375.","journal-title":"J Biol Chem"},{"issue":"1","key":"1118_CR16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.it.2013.10.005","volume":"35","author":"L Catrysse","year":"2014","unstructured":"Catrysse L, Vereecke L, Beyaert R, van Loo G. A20 in inflammation and autoimmunity. Trends Immunol. 2014;35(1):22\u201331.","journal-title":"Trends Immunol"},{"issue":"2","key":"1118_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85\u201397.","journal-title":"Nat Rev Immunol"},{"key":"1118_CR18","doi-asserted-by":"publisher","unstructured":"Wang ZV, Scherer PE. Adiponectin, the past two decades. Mol Cell Biol. 2016;8(2):93-100. doi: 10.1093\/jmcb\/mjw011 . Epub 2016 Mar 18.","DOI":"10.1093\/jmcb\/mjw011"},{"issue":"5","key":"1118_CR19","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1186\/ar4070","volume":"14","author":"F Fang","year":"2012","unstructured":"Fang F, Liu L, Yang Y, Tamaki Z, Wei J, Marangoni RG, Bhattacharyya S, Summer RS, Ye B, Varga J. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther. 2012;14(5):R229.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1118_CR20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00281-015-0499-z","volume":"37","author":"L Bossini-Castillo","year":"2015","unstructured":"Bossini-Castillo L, Lopez-Isac E, Mayes MD, Martin J. Genetics of systemic sclerosis. Semin Immunopathol. 2015;37(5):443\u201351.","journal-title":"Semin Immunopathol"},{"issue":"10","key":"1118_CR21","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ni1110","volume":"5","author":"DL Boone","year":"2004","unstructured":"Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004;5(10):1052\u201360.","journal-title":"Nat Immunol"},{"issue":"7","key":"1118_CR22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.15252\/embr.201338305","volume":"15","author":"A De","year":"2014","unstructured":"De A, Dainichi T, Rathinam CV, Ghosh S. The deubiquitinase activity of A20 is dispensable for NF-kappaB signaling. EMBO Rep. 2014;15(7):775\u201383.","journal-title":"EMBO Rep"},{"issue":"12","key":"1118_CR23","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/cdd.2015.52","volume":"22","author":"P Studer","year":"2015","unstructured":"Studer P, da Silva CG, Revuelta Cervantes JM, Mele A, Csizmadia E, Siracuse JJ, Damrauer SM, Peterson CR, Candinas D, Stroka DM, et al. Significant lethality following liver resection in A20 heterozygous knockout mice uncovers a key role for A20 in liver regeneration. Cell Death Differ. 2015;22(12):2068\u201377.","journal-title":"Cell Death Differ"},{"key":"1118_CR24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1742-2094-11-122","volume":"11","author":"RP Guedes","year":"2014","unstructured":"Guedes RP, Csizmadia E, Moll HP, Ma A, Ferran C, da Silva CG. A20 deficiency causes spontaneous neuroinflammation in mice. J Neuroinflammation. 2014;11:122.","journal-title":"J Neuroinflammation."},{"issue":"12","key":"1118_CR25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/cdd.2011.55","volume":"18","author":"S Lippens","year":"2011","unstructured":"Lippens S, Lefebvre S, Gilbert B, Sze M, Devos M, Verhelst K, Vereecke L, Mc Guire C, Guerin C, Vandenabeele P, et al. Keratinocyte-specific ablation of the NF-kappaB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ. 2011;18(12):1845\u201353.","journal-title":"Cell Death Differ"},{"issue":"7247","key":"1118_CR26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","volume":"459","author":"M Kato","year":"2009","unstructured":"Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, Niwa A, Chen Y, Nakazaki K, Nomoto J, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009;459(7247):712\u20136.","journal-title":"Nature"},{"issue":"11","key":"1118_CR27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/ard.2009.127928","volume":"69","author":"P Dieude","year":"2010","unstructured":"Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M, Melchers I, Hachulla E, Airo P, Diot E, et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis. 2010;69(11):1958\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"1118_CR28","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","volume":"22","author":"JE Martin","year":"2013","unstructured":"Martin JE, Assassi S, Diaz-Gallo LM, Broen JC, Simeon CP, Castellvi I, Vicente-Rabaneda E, Fonollosa V, Ortego-Centeno N, Gonzalez-Gay MA, et al. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet. 2013;22(19):4021\u20139.","journal-title":"Hum Mol Genet"},{"key":"1118_CR29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2015.07.005","volume":"64","author":"L Bossini-Castillo","year":"2015","unstructured":"Bossini-Castillo L, Lopez-Isac E, Martin J. Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun. 2015;64:53\u201365.","journal-title":"J Autoimmun."},{"key":"1118_CR30","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1038\/ncomms11703","volume":"7","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Wang W, Morales-Nebreda L, Feng G, Wu M, Zhou X, Lafyatis R, Lee J, Hinchcliff M, Feghali-Bostwick C, et al. Tenascin-C drives persistence of organ fibrosis. Nat Commun. 2016;7:11703.","journal-title":"Nat Commun."},{"issue":"1","key":"1118_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004005","volume":"11","author":"JM Mahoney","year":"2015","unstructured":"Mahoney JM, Taroni J, Martyanov V, Wood TA, Greene CS, Pioli PA, Hinchcliff ME, Whitfield ML. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. PLoS Comput Biol. 2015;11(1), e1004005.","journal-title":"PLoS Comput Biol"},{"key":"1118_CR32","doi-asserted-by":"crossref","unstructured":"Wang S, Wen F, Tessneer KL, Gaffney PM. TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus. Genes Immun. 2016;17(3):165\u201370.","DOI":"10.1038\/gene.2016.4"},{"issue":"6","key":"1118_CR33","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10875-012-9764-2","volume":"32","author":"D Li","year":"2012","unstructured":"Li D, Wang L, Fan Y, Song L, Guo C, Zhu F, Zhang L, Shi Y. Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Clin Immunol. 2012;32(6):1287\u201391.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1118_CR34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2775","volume":"10","author":"SG Hymowitz","year":"2010","unstructured":"Hymowitz SG, Wertz IE. A20: from ubiquitin editing to tumour suppression. Nat Rev Cancer. 2010;10(5):332\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1118_CR35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/jid.2009.318","volume":"130","author":"JL Sargent","year":"2010","unstructured":"Sargent JL, Milano A, Bhattacharyya S, Varga J, Connolly MK, Chang HY, Whitfield ML. A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J Invest Dermatol. 2010;130(3):694\u2013705.","journal-title":"J Invest Dermatol"},{"issue":"286","key":"1118_CR36","doi-asserted-by":"crossref","first-page":"ra63","DOI":"10.1126\/scisignal.2004177","volume":"6","author":"MY Balkhi","year":"2013","unstructured":"Balkhi MY, Iwenofu OH, Bakkar N, Ladner KJ, Chandler DS, Houghton PJ, London CA, Kraybill W, Perrotti D, Croce CM, et al. miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR. Sci Signal. 2013;6(286):ra63.","journal-title":"Sci Signal"},{"issue":"5","key":"1118_CR37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062223","volume":"8","author":"L Shao","year":"2013","unstructured":"Shao L, Oshima S, Duong B, Advincula R, Barrera J, Malynn BA, Ma A. A20 restricts wnt signaling in intestinal epithelial cells and suppresses colon carcinogenesis. PLoS One. 2013;8(5), e62223.","journal-title":"PLoS One"},{"key":"1118_CR38","unstructured":"Fang F, Marangoni MR, Zhou X, Hong W, Ye B, Yoshihide A, Sato S, Masui Y, Zhang C, Lakota K, Wei J, Hinchcliff ME, Scherer P, Otvos L, Varga J. Adiponectin is an endogenous anti-fibrotic and target in systemic sclerosis: novel link between fibrosis and metabolism. ACR. 2014."},{"key":"1118_CR39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4939-0398-6_5","volume":"809","author":"CG Silva da","year":"2014","unstructured":"da Silva CG, Minussi DC, Ferran C, Bredel M. A20 expressing tumors and anticancer drug resistance. Adv Exp Med Biol. 2014;809:65\u201381.","journal-title":"Adv Exp Med Biol."}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T02:21:10Z","timestamp":1568427670000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1118-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1118-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]},"article-number":"216"}}